Insider filing · TSHA
Kamran Alam
CHIEF FINANCIAL OFFICER
profile →
Taysha Gene Therapies, Inc.
TSHA · Healthcare · 11 filings in 24 months
ticker →
Kamran Alam sold $485K of Taysha Gene Therapies (TSHA)
Executed Jan 23, disclosed Jan 27, 4 days later.
Value, as filed
$485K
102,817 sh across 2 lots
Executed
Jan 23
the trade date, as filed
Disclosed
Jan 27
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KAKamran Alam (CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Taysha Gene Therapies, Inc. (TSHA). The largest single filing was $485K of TSHA (102,817 sh across 2 lots, as filed), executed Jan 23.
The name
TSHAHealthcare · Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kamran Alam in TSHA
TSHASALE
Taysha Gene Therapies, Inc.
$155K54,491 sh × $2.85
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET